Synthesis, characterization and anti-inflammatory activity of new 5- (3,4-dichlorophenyl)-2-(aroylmethyl) thio-1,3,4-oxadiaxoles

Arzneimittel-Forschung/Drug Research

Volumn 58, Issue 10, 2008, Pages 510-514

  Koksal, Meric ^a   Bilge, S Sirri ^b   Bozkurt, Ayhan ^b   Sahin, Z Sibel ^c   Isik, Samil ^c   Erol, Dilek Demir ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

1,3,4 oxadiazoles, antiinflammatory activity, S alkylation, synthesis, X ray crystallography

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; 5 (3,4 DICHLOROPHENYL) 2 (AROYLMETHYL)THIO 1,3,4 OXADIAZOLE; CARRAGEENAN; INDOMETACIN; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; MALE; NONHUMAN; PAW EDEMA; RAT; STOMACH ULCER; ULCEROGENESIS; X RAY CRYSTALLOGRAPHY;

EID: 55949113664     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296550     Document Type: Article

References (23)

1. Sorbera LA, Lesson PA, Castanar J, Castanar RM. Valdecoxib and parecoxib sodium. Analgesic, antiarthritic, cyclooxygenase-2 inhibitors. Drugs Future. 2001;26:133-140.
2. Palomer A, Cabre F, Pascual J, Campos J, Trugillo MA, Entrera A, et al. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem. 2002;45:1402-1411.
3. Talley JJ, Brown DL, Carter JS, Graneto MJ, Koboldt CM, Masferrer JL, et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. J Med Chem. 2000;43:775-777.
4. Tammara VK, Narurkar MM, Crider AM, Khan MA. Morpholinoalkyl ester prodrugs of diclofenac: Synthesis, in vitro and in vivo evaluation. J Pharm Sci. 1994;83:644-648.
5. Smith CJ, Zhang Y, Kobolt CM, Muhammad J, Zwefel BS, Shaffer A, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998;95:13313-13318.
6. Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, et al. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2000;43:370-377.
7. Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ. Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indometacin, as selective cyclooxygenase-2 inhibitors. J Med Chem. 2000;43:2860-2870.
8. Duflos M, Nourrisson MR, Brelet J, Courant J, Le Baut G., Grimaud N, et al. N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors. Eur J Med Chem. 2001;36:545-553.
9. Kalgutkar AS, Crews BC, Rowlinson SW, Garner C, Seibert K, Marnett LJ. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science. 1998;280:1268-1270.
10. Burbuliene MM, Jakubkiene V, Mekuskiene G, Udrenaite E, Smicius R, Vainilavicius P. Synthesis and anti-inflammatory activity of derivatives of 5-[(2-disubstitutedamino-6-methyl-pyrimidin-4-yl)-sulfanylmethyl]-3H-1,3, 4-oxadiazole-2-thiones. Farmaco. 2004;59:767-774.
11. Kadi AA, El-Brollosy NR, Al-Deeb OA, Habib EE., Ibrahim TM, El-emam AA. Synthesis, antimicrobial and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1,3,4-oxadiazoles and 2-(1-adamantylamino)-5- substituted-1,3,4-thiadiazoles. Eur J Med Chem. 2007;42:235-242.
12. Palaska E, Sahin G, Kelicen P, Durlu NT, Altinok G. Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. Farmaco. 2002;57:101-107.
13. Boschelli DH, Connor DT, Bornemeier DA, Dyer RD, Kennedy JA, Kuipers PJ, et al. 1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities. J Med Chem. 1993;36:1802-1810.
14. Jakubkiene V, Burbuliene MM, Mekuskiene G, Udrenaite E, Gaidelis P, Vainilavicius P. Synthesis and anti-inflammatory activity of 5-(6-methyl-2-substituted-4-pyrimidinyl-oxymethyl)-1,3,4-oxadiazole-2-thiones and their 3-morpholinomethyl derivatives. Farmaco. 2003;58:323-328.
15. Narayana B, Raj KKV, Ashalatha BV, Kumari NS. Synthesis of some new 2-(6-methoxy-2-naphtyl)-5-aryl-1,34-oxadiazoles as possible non-steroidal and-inflammatory and analgesic agents. Arch Pharm Chem Life Sci. 2005;338:373-377.
16. Raman K, Parmar SS, Salzman SK. Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J Pharm Sci. 1989;78:999-1002.
17. Nargund LCG, Reddy GRN, Hariprasad V. Anti-inflammatory activity of substituted 1,3,4-oxadiazoles. J Pharm Sci. 1994;83:246-248.
18. Raman K, Singh KH, Salzman SK, Parmar SS. Substituted thiosemicarbazides and corresponding cyclized 1,3,4-oxadiazoles and their anti-inflammatory activity. J Pharm Sci. 1993;82:167-169.
19. Mullican MD, Wilson MW, Connor DT, Kosdan CR, Schrier DJ, Dyer RD. Design of 5-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3,4-thiadiazoles, -1,3,4-oxadiazoles, and -1,2,4-triazoles as orally-active, nonulcerogenic antiinflammatory agents. J Med Chem. 1993;36:1090-1099.
20. Winter CA, Risley EA, Nuss GW. Carrageenin-induced edema in hind paw of the rats as an assay for antiinflammatory drugs. Proc Soc Exp Biol Med. 1962;111: 544-552.
21. Liang-Zhong X, Guan-Ping Y, Shu-Mei Y, Kai Z, Shuang-Hua Y. 2- {5-[(1H-1,2,4-Triazol-1-yDmethyl]-1,3,4-oxadiazol-2-ylthio}-1-(2, 4-dichlorophenyl)ethanone. Acta Cryst. 2005; E61:o3375-o3376.
22. Picot D, Loll PJ, Garavito M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 Nature. 1994;367:243-249.
23. Kurumball RG, Stevens AM, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature. 1996;384:644-648.